Search results
Found 6782 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Wearing face coverings protected wearers from COVID-19 infection – large scale study
Coronavirus COVID-19 General Research
28 October 2021
People who wore face coverings or masks outside of the home, and were more exposed to infection due to their circumstances, had ‘significantly’ lower rates of COVID-19 infection, according to research published in BMJ Open today, led by Oxford’s Leverhulme Centre for Demographic Science.
Oxford-led team given £6.6m to map uncharted networks in the progression of Parkinson’s
General Research
26 October 2021
A major new $9 million (£6.6 million) project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. It is the only UK-led ASAP project this year, and the first ever to be led by Oxford.
Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis
General Research
26 October 2021
Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.
Oxford researchers awarded funding to complete community COVID-19 antiviral trial
Coronavirus COVID-19 General Research
26 October 2021
Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.
New therapeutic targets identified to treat inflammatory bowel disease
General Research
22 October 2021
Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.
Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile
General Research
22 October 2021
A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.
Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age
General Research
21 October 2021
A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.
Drug could help diabetic hearts recover after heart attack - Oxford research
General Research
20 October 2021
Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.
Call for supervisors: Academic special interest projects for Graduate-entry Medicine students
19 October 2021
Students in Years 1 & 2 of the 4-year Graduate Entry Medicine programme have the opportunity to pursue an area of academic special interest. We are seeking academic supervisors to support this work.
Largest ever global study of tuberculosis identifies genetic causes of drug resistance
General Research
19 October 2021
Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.
AIMday in Women's Health - registration for academics now open
Events Innovation
14 October 2021
Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.
Peter Horby receives prestigious award for outstanding service to public health
Awards and Appointments Coronavirus COVID-19 General
14 October 2021
The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.
Equity share policy for new spinouts
12 October 2021
Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme
Awards and Appointments General Innovation
11 October 2021
The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.
Researchers set out steps to address mental health effects of the pandemic on young people
Coronavirus COVID-19 General Research
8 October 2021
Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.
Anti-cancer drug derived from fungus shows promise in clinical trials
Clinical Trials General Innovation Research
7 October 2021
A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.
Update on UKRI block grant
7 October 2021
Professor Trish Greenhalgh Highly Commended in the O²RB Excellence in Impact Awards 2021
Awards and Appointments General
6 October 2021
Congratulations to Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences) who has been Highly Commended in the O²RB Excellence in Impact Awards 2021.